Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
In this edition of Device Week, Medtech Insight managing editor Marion Webb reports on her discussions with diagnostic company executives at the recent American Association for Clinical Chemistry meeting in Anaheim. And senior reporter Catherine Longworth previews her feature on MDisrupt, a new company that touts itself as the world’s first medical diligence company for the healthcare industry.
In this week's podcast, Medtech Insight’s Ferdous Al-Faruque chats with Elizabeth Orr about the the latest safety concerns over cardiac devices such as drug-eluting stents and implantable cardioverter defibrillators. They also discuss the agency’s recently released user-fee rates and how they’ve increased historically.
Device Week, 2 August 2019 – Global Hearing Aid Market Growing Fast; Zimmer Biomet Continues Turnaround
In this week's podcast, Medtech Insight’s Catherine Longworth chats to Marion Webb about the growth of the global hearing aid market, which is set to rise from $7.7bn in 2018 to $11bn by 2023. Longworth also speaks to Reed Miller to discuss Zimmer Biomet’s second quarter results and its long-term plan to return to steady growth.
No one likes unhappy surprises, especially when it comes to medical billing. In this week's Medtech Insight podcast, executive editor Shawn M. Schmitt and senior reporter Sue Darcey talk about so-called surprise billing by hospitals and other health-care facilities, how legislation wending its way through the US Congress is aiming to curb it, and why the medtech industry should care.
Device Week, 19 July 2019 – All About Earnings: Johnson & Johnson's Leadership Remains Optimistic; Abbott Delivers Strong Second Quarter
In this edition of Device Week, Medtech Insight's managing editor Marion Webb chats with deputy editor Reed Miller about recent earning reports from medtech giants Johnson & Johnson and Abbott.
Device Week, 8 July 2019: Highlights From The AdvaMed Conference; Boston Scientific Continues To Build Case For Watchman
In this edition of Device Week, Medtech Insight’s Marion Webb reviews her interview with Omron Healthcare CEO Ranndy Kellogg at the recent AdvaMed conference in San Francisco. Reed Miller discusses the latest cost-effectiveness study of Boston Scientific’s Watchman left-atrial appendage closure device.
It may often seem like Brexit is the only story in town in the UK, but within health care and medtech a lot of system transformation and future planning for access to medtech innovation is underway, as this installment of Medtech Insight's Device Week podcast with Ashley Yeo and Amanda Maxwell underlines.
Device Week, 20 June 2019: ADA 2019 Key Players; Trial Results From Global Kinetics And Myriad Genetics
In this edition of Device Week, Medtech Insight's Catherine Longworth chats with Marion Webb about her upcoming Market Intelligence story based on interviews with the biggest players in the diabetes market at the recent annual American Diabetes Association meeting. And Reed Miller discusses Global Kinetics' recent data on its Personal KinetiGraph that can help identify Parkinson's patients most likely to benefit from device-assisted therapy and Myriad Genetics' POLO trial results.
In this week's Medtech Insight podcast, executive editor Shawn M. Schmitt and senior reporter Sue Darcey discuss recent reporting on efforts by US senators to control and stop Chinese researchers in the US from using their research jobs at the National Institutes of Health, and at American medical colleges and universities, to steal genomic data and share it with the Chinese government.
Device Week, 7 June 2019: AdvaMed Medtech In San Francisco; Inhalation And Respiratory Drug Delivery Summit In NYC
In this edition of Device Week, Medtech Insight's Marion Webb discusses the AdvaMed MedTech Conference in San Francisco that focused on digital-health devices, and senior reporter Catherine Longworth discusses the Inhalation Respiratory Drug Delivery device meeting in New York City that explored emerging trends and challenges in bringing respiratory products to market.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.